« Previous
Next »
Journal of the American Society of Hypertension
Volume 1, Issue 5
, Pages 296-301
, September 2007
Mentors, role models, and matters of the heart
References
- . Am J Cardiol. 2003;91:646–648
- . Memoriam. In: Edward D, Freis MD editor. Hypertension. 45:2005;p. 825–827
- . Hemodynamics of hypertension. Physiol Rev. 1960;40:27–54
- . Electrocardiographic changes reflecting left atrial abnormality in hypertension. Circulation. 1966;34:818–822
- . Left atrial abnormality and ventricular pre-ejection period in hypertension. Dis Chest. 1969;55:214–218
- . Clinical-physiological correlations in the development of hypertensive heart disease. Circulation. 1971;44:446–455
- . Pathophysiologic assessment of hypertensive heart disease with echocardiography. Am J Cardiol. 1977;39:789–795
- . The First Irvine H (Page lecture: the mosaic of hypertension; past, present, and future). J Hypertens. 1988;6(suppl 4):S2–S11
- . Hyperdynamic beta-adrenergic circulatory state. Arch Intern Med. 1966;117:614–619
- . Functional correlates of plasma renin activity in hypertensive patients. Circulation. 1970;41:555–567
- . Controversies in cardiovascular research: similarities of genetic (spontaneous) hypertension (Man and rat). Circ Res. 1981;48:309–319
- . Hemodynamic and myocardial function in young and old normotensive and spontaneously hypertensive rats. Circ Res. 1973;32:28–38
- . Pumping ability and of the hypertrophying left ventricle of the spontaneously hypertensive rat. Circ Res. 1976;38:423–429
- . Ventricular morphology and pumping ability of exercised spontaneously hypertensive rats. Am J Physiol. 1978;235:H193–H199
- . Cardiac function and morphology with aging in the spontaneously hypertensive rat. Am J Physiol. 1979;237:H461–H468
- . Risk mechanisms in hypertensive heart disease. Hypertension. 1999;34:782–789
- . Corcoran Memorial Lecture: influence of nitric oxide and angiotensin II on renal involvement in hypertension. Hypertension. 1997;29:188–193
- . Target organ involvement in hypertension: a realistic promise of prevention and reversal. Med Clin North Am. 2004;88:209–221
- . Uric acid: its relationship to renal hemodynamics and the renal renin-angiotensin system. Curr Hypertens Rep. 2006;8:120–124
- . Uric acid: a risk factor for coronary heart disease. JAMA. 1993;270:378–379
- . Promise of prevention and reversal of target organ involvement in hypertension. JRAAS. 2001;2(1):4–9
- . A renewed call to mentor. Hypertension. 2000;36:309–311
- . The role of sodium in hypertension is more complex than simply elevating arterial pressure. Nat Clin Pract Cardiovasc Med. 2004;1:24–30
- . Cardiac structural and functional responses to salt loading in SHR. Am J Physiol (Heart Circ Physiol). 2004;287:H767–H772
- . Hypertension and multifactorial role of salt. Lab Med. 2005;36:2–5
- Myocardial fibrosis, impaired coronary hemodynamics, and biventricular dysfunction in salt-loaded SHR. Am J Physiol Heart Circ Physiol. 2006;290:H1503–H1509
- . Salt-loading produces severe renal hemodynamic dysfunction independent of arterial pressure in spontaneously hypertensive rats. Am J Physiol Circ Physiol. 2007;292:H814–H819
- . The salt conundrum: a hypothesis. Hypertension. 2007;50:161–166
Conflict of interest: none.
PII: S1933-1711(07)00130-1
doi: 10.1016/j.jash.2007.06.002
© 2007 American Society of Hypertension. Published by Elsevier Inc. All rights reserved.
« Previous
Next »
Journal of the American Society of Hypertension
Volume 1, Issue 5
, Pages 296-301
, September 2007
